Sorry, you need to enable JavaScript to visit this website.

Tate & Lyle disposes of Orsan Vietnam

| Filed in:
Tate & Lyle PLC (“Tate & Lyle”) announces the sale by its subsidiary Amylum Group of its 100% shareholding in Orsan Vietnam to Vedan Enterprise Corporation, a Taiwanese monosodium glutamate manufacturer. The net assets of Orsan Vietnam at the end of March 2001 amounted to approximately £1 million. The disposal is part of Tate & Lyle’s ongoing strategy to divest of non-core or under-performing businesses and the proceeds will be used to reduce Group debt.

Click here for our press image gallery

About Tate & Lyle: 
Tate & Lyle is a world leader in ingredient solutions for healthier food and beverages. Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, mouthfeel and fortification, we develop solutions which reduce sugar, calories and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, soups, sauces and dressings.

We have more than 3,500 employees working in around 60 locations across 39 countries. Tate & Lyle's purpose is Transforming Lives Through the Science of Food and through our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2022, Tate & Lyle revenue from continuing operations totalled £1.4 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on TwitterLinkedin or Facebook.